Al Nahdi Medical Company SCJSC
SAU:4164
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
SA |
|
S
|
SP Group A/S
F:1PU2
|
DK |
|
GSK plc
F:GS71
|
UK |
|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
US |
|
B
|
Baxter International Inc
BMV:BAX
|
US |
|
C
|
Christian Dior SE
SWB:DIO
|
FR |
|
Adapthealth Corp
NASDAQ:AHCO
|
US |
|
Pepkor Holdings Ltd
OTC:PPKRF
|
ZA |
|
E
|
EDP Energias de Portugal SA
SWB:EDP
|
PT |
|
Renaissancere Holdings Ltd
NYSE:RNR
|
BM |
Wall St Price Targets
Price Targets Summary
Al Nahdi Medical Company SCJSC
According to Wall Street analysts, the average 1-year price target for Al Nahdi Medical Company SCJSC is 128.03 SAR with a low forecast of 106.2 SAR and a high forecast of 149.1 SAR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Al Nahdi Medical Company SCJSC's stock price target?
Price Target
128.03
SAR
According to Wall Street analysts, the average 1-year price target for Al Nahdi Medical Company SCJSC is 128.03 SAR with a low forecast of 106.2 SAR and a high forecast of 149.1 SAR.
What is the Revenue forecast for Al Nahdi Medical Company SCJSC?
Projected CAGR
8%
Over the last 7 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 4 years is 8%.
What is the Gross Profit forecast for Al Nahdi Medical Company SCJSC?
Projected CAGR
8%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 4 years is 8%.
What is the Operating Income forecast for Al Nahdi Medical Company SCJSC?
Projected CAGR
8%
Over the last 7 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 4 years is 8%.
What is the Pre-Tax Income forecast for Al Nahdi Medical Company SCJSC?
Projected CAGR
9%
Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 9%.
What is the Net Income forecast for Al Nahdi Medical Company SCJSC?
Projected CAGR
7%
Over the last 7 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 4 years is 7%.
